Comparison of SVEAT and HEART scoring in acute chest pain

Aynur Yurtseven; Cemil Kavalcı; Afşin Emre Kayıpmaz

Makale detayları

Comparison of SVEAT and HEART scoring in acute chest pain

Yazarlar:

Aynur Yurtseven | Cemil Kavalcı | Afşin Emre Kayıpmaz

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Acil Tıp

Dergi:

Anatolian Current Medical Journal Vol.7 Issue 5, pp.546-550

Belge Tipi:

Makale

Yayın Tarihi:

9/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001358250

pISSN:

2718-0115

Anahtar kelimeler:

Özet:

 Aims: It is very important to evaluate patients presenting with chest pain in terms of major adverse cardiovascular events MACE and many risk scoring systems have been developed for this purpose. In this study, we aimed to evaluate the MACE prediction performance of the newly developed symptoms, history of vascular disease, electrocardiography, age and troponin SVEAT score for patients presenting with chest pain. Methods: This study was designed as a retrospective observational clinical trial. MACE occurring within 30 days; Myocardial infarction MI, percutaneous coronary intervention PCI, coronary artery bypass graft CABG and sudden cardiac death were considered the primary endpoints of the study. Patients over 18 years of age presenting with chest pain were included in the study. Patients with ST segment elevation on electrocardiography ECG, hemodynamic instability and traumatic chest pain were excluded. Results: The study included 557 patients and the mean age was 54.5212.56 and the age distribution range was 23-95. Significant results for SVEAT score AUC:0.988, 95CI:0.978-0.997, p0.001 and history, electrocardiography, age, risk factors and troponin HEART score AUC:0.960, 95CI:0.942-0.979, p0.001 were obtained from ROC analysis of the effect of SVEAT and HEART scores on MACE. Conclusion: The newly developed SVEAT score was superior to the HEART score in predicting adverse negative cardiac events in patients presenting with chest pain.

 Aims: It is very important to evaluate patients presenting with chest pain in terms of major adverse cardiovascular events MACE and many risk scoring systems have been developed for this purpose. In this study, we aimed to evaluate the MACE prediction performance of the newly developed symptoms, history of vascular disease, electrocardiography, age and troponin SVEAT score for patients presenting with chest pain. Methods: This study was designed as a retrospective observational clinical trial. MACE occurring within 30 days; Myocardial infarction MI, percutaneous coronary intervention PCI, coronary artery bypass graft CABG and sudden cardiac death were considered the primary endpoints of the study. Patients over 18 years of age presenting with chest pain were included in the study. Patients with ST segment elevation on electrocardiography ECG, hemodynamic instability and traumatic chest pain were excluded. Results: The study included 557 patients and the mean age was 54.5212.56 and the age distribution range was 23-95. Significant results for SVEAT score AUC:0.988, 95CI:0.978-0.997, p0.001 and history, electrocardiography, age, risk factors and troponin HEART score AUC:0.960, 95CI:0.942-0.979, p0.001 were obtained from ROC analysis of the effect of SVEAT and HEART scores on MACE. Conclusion: The newly developed SVEAT score was superior to the HEART score in predicting adverse negative cardiac events in patients presenting with chest pain.

 Aims: It is very important to evaluate patients presenting with chest pain in terms of major adverse cardiovascular events MACE and many risk scoring systems have been developed for this purpose. In this study, we aimed to evaluate the MACE prediction performance of the newly developed symptoms, history of vascular disease, electrocardiography, age and troponin SVEAT score for patients presenting with chest pain. Methods: This study was designed as a retrospective observational clinical trial. MACE occurring within 30 days; Myocardial infarction MI, percutaneous coronary intervention PCI, coronary artery bypass graft CABG and sudden cardiac death were considered the primary endpoints of the study. Patients over 18 years of age presenting with chest pain were included in the study. Patients with ST segment elevation on electrocardiography ECG, hemodynamic instability and traumatic chest pain were excluded. Results: The study included 557 patients and the mean age was 54.5212.56 and the age distribution range was 23-95. Significant results for SVEAT score AUC:0.988, 95CI:0.978-0.997, p0.001 and history, electrocardiography, age, risk factors and troponin HEART score AUC:0.960, 95CI:0.942-0.979, p0.001 were obtained from ROC analysis of the effect of SVEAT and HEART scores on MACE. Conclusion: The newly developed SVEAT score was superior to the HEART score in predicting adverse negative cardiac events in patients presenting with chest pain.

 Aims: It is very important to evaluate patients presenting with chest pain in terms of major adverse cardiovascular events MACE and many risk scoring systems have been developed for this purpose. In this study, we aimed to evaluate the MACE prediction performance of the newly developed symptoms, history of vascular disease, electrocardiography, age and troponin SVEAT score for patients presenting with chest pain. Methods: This study was designed as a retrospective observational clinical trial. MACE occurring within 30 days; Myocardial infarction MI, percutaneous coronary intervention PCI, coronary artery bypass graft CABG and sudden cardiac death were considered the primary endpoints of the study. Patients over 18 years of age presenting with chest pain were included in the study. Patients with ST segment elevation on electrocardiography ECG, hemodynamic instability and traumatic chest pain were excluded. Results: The study included 557 patients and the mean age was 54.5212.56 and the age distribution range was 23-95. Significant results for SVEAT score AUC:0.988, 95CI:0.978-0.997, p0.001 and history, electrocardiography, age, risk factors and troponin HEART score AUC:0.960, 95CI:0.942-0.979, p0.001 were obtained from ROC analysis of the effect of SVEAT and HEART scores on MACE. Conclusion: The newly developed SVEAT score was superior to the HEART score in predicting adverse negative cardiac events in patients presenting with chest pain.

Makale detayları

Comparison of SVEAT and HEART scoring in acute chest pain

Yazarlar:

Aynur Yurtseven | Cemil Kavalcı | Afşin Emre Kayıpmaz

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Acil Tıp

Dergi:

Anatolian Current Medical Journal Vol.7 Issue 5, pp.546-550

Belge Tipi:

Makale

Yayın Tarihi:

9/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001358250

pISSN:

2718-0115

Chest pain

emergency

risk score

cardiovascular eventChest pain

emergency

risk score

cardiovascular event

Sayı

Makale detayları

Yazarlar: Aynur Yurtseven | Cemil Kavalcı | Afşin Emre Kayıpmaz

Yayıncı: MediHealth Academy Yayıncılık

Ana Başlıklar: Acil Tıp

Dergi: Anatolian Current Medical Journal Vol.7 Issue 5, pp.546-550

Belge Tipi: Makale

Yayın Tarihi: 9/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001358250

pISSN: 2718-0115

Sayı

Yazarlar:

Aynur Yurtseven | Cemil Kavalcı | Afşin Emre Kayıpmaz

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Acil Tıp

Dergi:

Anatolian Current Medical Journal Vol.7 Issue 5, pp.546-550

Belge Tipi:

Makale

Yayın Tarihi:

9/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001358250

pISSN:

2718-0115